典型文献
Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris:a population-based retrospective cohort study
文献摘要：
Objective:This study aimed to explore the effects of Chinese patent medicine (CPM) in reducing the incidence of major adverse cardiovascular events (MACE) in patients with coronary heart disease (CHD) angina pectoris and improving clinical effectiveness and provide evidence for its use as clinical adjuvant therapy. Methods:Twenty-eight thousandfive hundred and seventeen patients hospitalized with CHD angina pectoris from 6 hospitals were divided into CPM group (n=11,374) and non-CPM group (n=17,143) to evaluate the incidence of MACE, including myocardial infarction, percutaneous coronary intervention, and coronary artery bypass grafting. Results:The incidence of MACE in the CPM group was lower than that in the non-CPM group. CPM therapy was an independent protective factor that reduced the overall risk of MACE [adjusted hazard ratio=0.40, 95％confidence interval (0.33;0.49)]. Patients in the CPM group who received one, two, or three types of CPM could benefit from adjuvant treatment with CPM, and taking more types of CPM was associated with a lower risk of MACE. In addition, the male population was better than the female population at taking CPM, and middle-aged people aged 55 to 64 were more suited to take CPM based on Western medicine. Conclusions:The use of CPM as adjuvant therapy can decrease the occurrence of MACE in patients with CHD angina pectoris, especially in men and middle-aged people, and the drug treatment plan should be optimized accordingly. However, this conclusion needs further verification by prospective cohort studies in the future.
文献关键词：
中图分类号：
作者姓名：
Yijia Liu;Zhu Li;Xu Wang;Tongyao Ni;Mei Ma;Yuanyuan He;Rongrong Yang;Mingchi Luo
作者机构：
Tianjin University of Traditional Chinese Medicine,Tianjin,China;Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin,China
文献出处：
引用格式：
[1]Yijia Liu;Zhu Li;Xu Wang;Tongyao Ni;Mei Ma;Yuanyuan He;Rongrong Yang;Mingchi Luo-.Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris:a population-based retrospective cohort study)[J].针灸和草药（英文）,2022(02):109-117
A类：
thousandfive
B类：
Effects,adjuvant,Chinese,patent,medicine,therapy,major,adverse,cardiovascular,events,patients,coronary,heart,disease,angina,pectoris,population,retrospective,cohort,study,Objective,This,aimed,explore,effects,CPM,reducing,incidence,MACE,CHD,improving,clinical,effectiveness,provide,evidence,its,use,Methods,Twenty,eight,hundred,seventeen,hospitalized,from,hospitals,were,divided,into,group,evaluate,including,myocardial,infarction,percutaneous,intervention,artery,bypass,grafting,Results,was,lower,than,that,independent,protective,reduced,overall,risk,adjusted,hazard,ratio,confidence,interval,Patients,who,received,one,two,three,types,could,benefit,treatment,taking,more,associated,In,addition,better,female,middle,aged,people,suited,take,Conclusions,can,decrease,occurrence,especially,drug,plan,should,optimized,accordingly,However,this,conclusion,needs,further,verification,prospective,studies,future
AB值：
0.490229
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
